Tech Company Financing Transactions

3-V Biosciences Funding Round

3-V Biosciences secured a $20 million Series C investment round on 6/24/2013. Investors included Kleiner Perkins Caufield & Byers and New Enterprise Associates.

Transaction Overview

Company Name
3-V Biosciences
Announced On
6/24/2013
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors

Kleiner Perkins Caufield & Byers (Beth Seidenberg)

New Enterprise Associates (Robert Garland)

Proceeds Purpose
Proceeds from the financing will be used to advance 3-V's lead oncology candidate into a Phase 1 clinical trial and to conduct ongoing preclinical studies of multiple virology leads generated by the company's integrated drug discovery process.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3715 Haven Ave. 220
Menlo Park, CA 94025
USA
Phone
(650) 561-8600
Website
www.3vbio.com
Email Address
[email protected]
Overview
3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Profile
3-V Biosciences LinkedIn Company Profile
Social Media
3-V Biosciences Company Twitter Account
Company News
3-V Biosciences News
Facebook
3-V Biosciences on Facebook
YouTube
3-V Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
George Kemble
  George Kemble LinkedIn Profile  George Kemble Twitter Account  George Kemble News  George Kemble on Facebook
Chief Medical Officer
William McCulloch
  William McCulloch LinkedIn Profile  William McCulloch Twitter Account  William McCulloch News  William McCulloch on Facebook
Vice President
Douglas Buckley
  Douglas Buckley LinkedIn Profile  Douglas Buckley Twitter Account  Douglas Buckley News  Douglas Buckley on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/24/2013: ZocDoc venture capital transaction
Next: 6/24/2013: PLAiR venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.